Eurofins BioPharma Product Testing Sweden AB — FDA Facility Profile

FEI 3008763211

Eurofins BioPharma Product Testing Sweden AB is an FDA-registered facility (FEI 3008763211) located in Uppsala, SE. Registered operations: ANALYSIS. RegDataLab tracks 5 FDA inspections at this facility.

Reviewing Eurofins BioPharma Product Testing Sweden AB as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Eurofins BioPharma Product Testing Sweden AB yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

What FDA found at this site

Latest inspection
Jun 19, 2024: Voluntary Action Indicated (VAI)
Inspections on record
5 (4 VAI, 1 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Jun 19, 2024Voluntary Action Indicated (VAI)No citations listed
Dec 8, 2022Voluntary Action Indicated (VAI)No citations listed
May 12, 2017No Action Indicated (NAI)No citations listed
Mar 13, 2015Voluntary Action Indicated (VAI)Lab controls established, including changes (21 CFR 211.160(a))
Complete test data included in records (21 CFR 211.194(a))
Deviations from laboratory control requirements (21 CFR 211.160(a))
Feb 18, 2011Voluntary Action Indicated (VAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
Defined areas of adequate size for operations (21 CFR 211.42(c))
Calibration/Inspection/Checking not done (21 CFR 211.68(a))
Following/documenting laboratory controls (21 CFR 211.160(a))
and 2 more

Facility details

Company
Eurofins BioPharma Product Testing Sweden AB
Location
Uppsala (SE)
Registration Expires
Dec 31, 2027
Operations
ANALYSIS
Source
decrs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.